Literature DB >> 35869743

Towards De-Implementation of low-value thyroid care in older adults.

Jennifer M Perkins1, Maria Papaleontiou2,3.   

Abstract

PURPOSE OF REVIEW: This review discusses the current literature regarding low-value thyroid care in older adults, summarizing recent findings pertaining to screening for thyroid dysfunction and management of hypothyroidism, thyroid nodules and low-risk differentiated thyroid cancer. RECENT
FINDINGS: Despite a shift to a "less is more" paradigm for clinical thyroid care in older adults in recent years, current studies demonstrate that low-value care practices are still prevalent. Ineffective and potentially harmful services, such as routine treatment of subclinical hypothyroidism which can lead to overtreatment with thyroid hormone, inappropriate use of thyroid ultrasound, blanket fine needle aspiration biopsies of thyroid nodules, and more aggressive approaches to low-risk differentiated thyroid cancers, have been shown to contribute to adverse effects, particularly in comorbid older adults.
SUMMARY: Low-value thyroid care is common in older adults and can trigger a cascade of overdiagnosis and overtreatment leading to patient harm and increased healthcare costs, highlighting the urgent need for de-implementation efforts.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35869743      PMCID: PMC9458619          DOI: 10.1097/MED.0000000000000758

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.626


  107 in total

Review 1.  The role of thyroid hormones in depression.

Authors:  C Kirkegaard; J Faber
Journal:  Eur J Endocrinol       Date:  1998-01       Impact factor: 6.664

2.  Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.

Authors:  Paolo Goffredo; Samantha M Thomas; Michaela A Dinan; Jennifer M Perkins; Sanziana A Roman; Julie A Sosa
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

3.  Thyroid Hormone Use in the United States, 1997-2016.

Authors:  Michael E Johansen; Julie P Marcinek; Jonathan Doo Young Yun
Journal:  J Am Board Fam Med       Date:  2020 Mar-Apr       Impact factor: 2.657

4.  Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study.

Authors:  H R Harach; K O Franssila; V M Wasenius
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

Review 5.  Thyroid Nodule Evaluation and Management in Older Adults: A Review of Practical Considerations for Clinical Endocrinologists.

Authors:  Naykky Singh Ospina; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2021-02-12       Impact factor: 3.443

6.  Concurrent Use of Thyroid Hormone Therapy and Interfering Medications in Older US Veterans.

Authors:  Rachel Livecchi; Antoinette B Coe; David Reyes-Gastelum; Mousumi Banerjee; Megan R Haymart; Maria Papaleontiou
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

7.  Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.

Authors:  Robert W Flynn; Sandra R Bonellie; Roland T Jung; Thomas M MacDonald; Andrew D Morris; Graham P Leese
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

8.  Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: A National Survey of Low- and High-Volume Surgeons.

Authors:  Alexandria D McDow; Megan C Saucke; Nicholas A Marka; Kristin L Long; Susan C Pitt
Journal:  Ann Surg Oncol       Date:  2021-05-03       Impact factor: 5.344

9.  Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.

Authors:  Rasiah Thayakaran; Nicola J Adderley; Christopher Sainsbury; Barbara Torlinska; Kristien Boelaert; Dana Šumilo; Malcolm Price; G Neil Thomas; Konstantinos A Toulis; Krishnarajah Nirantharakumar
Journal:  BMJ       Date:  2019-09-03

Review 10.  Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime.

Authors:  Leonidas H Duntas; Jacqueline Jonklaas
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.